CTRI/2010/091/002822已完成未知
STUDY TO EVALUATE SAFETY OF BENZALKONIUM CHLORIDE FREE LATANOPROST OPHTHALMIC SOLUTION 0.005% IN SUBJECTS WITH GLAUCOMA.
Sun Pharma Advanced Research Company Ltd, 17/B, Mahal Industrial Estate, Mahakali Caves Road, Andheri-E, Mumbai-400093, Maharashtra, India.0 个研究点目标入组 46 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 46
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •18 years of age or older Either gender and any race,taking Latanoprost (containing BAK) monotherapy at least 12 months,tear break up time less than 6 seconds
排除标准
- •Participation in another clinical study within the last thirty (30) days,Clinically significant systemic disease, which might interfere with the study,History of non-compliance to medical regimens or unwilling to comply with the study protocol,Refusal or inability to give written informed consent,Angle closure glaucoma or a history of acute angle closure treated with a peripheral iridotomy,Progressive retinal or optic nerve disease apart from glaucoma,Any opacity or subject uncooperativeness that restricts adequate examination of the ocular fundus or anterior chamber,Clinically significant ocular disease (e.g. corneal edema, uveitis, severe keratoconjunctivitis sicca) which might interfere with the study.
研究者
相似试验
已完成
4 期
Comparative efficacy and safety of preserved and preservative-free anti-glaucoma therapyCTRI/2016/06/007001Government Medical College Patiala30
招募中
Unknown
Effectiveness of Bethanechol chloride in bladder disorders patients.CTRI/2023/05/052672Ranchi Urology Center (RUC)
Unknown
4 期
An Efficacy Study of BCS Clearing the Oral Colonized Bacterium in Hospitalized Patients With COPDChronic Obstructive Pulmonary DiseaseNCT02269800Lustre Pharmaceutical Lab Co., Ltd60
尚未招募
不适用
The effects of topical Benzalkonium chloride (BAC) wound gel on chronic infections in Diabetes Related Foot Ulcers (DRFUs): An in vivo proof of concept studydiabetesdiabetic foot ulcerACTRN12623000154606South Western Sydney Local Health District20
尚未招募
2 期
Efficacy and safety of Chlorpromazine in the treatment of COVID-19 patientsIRCT20200913048708N1Mazandaran University of Medical Sciences60